RAPID DISPATCH
24/H dispatch
5 in stock
Teosyal® RHA 1 is specially designed to deeply nourish the skin and redensify the dermis. It brightens the forehead, redraws the cheeks, fills furrows, recreates smile harmony and revitalises the skin. The ingredients diffuse between the skin cells, increasing their activity and redensifying the skin without creating volume. The skin regains a youthful and fresh appearance. After acting on the skin cells, the ingredients are gradually reabsorbed, like any natural skin component, leaving the skin smooth and regenerated.
USE MEDICAL STRICT. Medical device. Injection of hyaluronic acid. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
Teosyal® RHA 1 is a gel:
- Viscoleastic, sterile, non-pyrogenic, transparent, of non-animal origin based on hyaluronic acid.
- With high elasticity capacity.
- Long-lasting, natural-looking results.
- TEOXANE
- NAME: TEOSYAL RHA 1
- COMPOSITION: Hyaluronic acid 15 mg/mL, phosphate buffer q.b. to 1 mL, Lidocaine 0.3% by mass.
- PRESENTATION: 2 x 1 ml.
- NEEDLES: 2 x 30G½.
- INDICATIONS: Prevents skin ageing, redensifies the skin in depth, improves skin radiance.
- INJECTION DEPTH: Medium dermis.
- DURATION: At least 12 months.
- USE: Strict medical use.
- Syringes: 2 x 1 ml.
- Needles: 2 x 30G½.
- Each box contains two pre-filled disposable syringes of Teosyal® RHA 1 to 1 ml, 2 sterile 30G needles, 2 traceability labels and a package insert.
Cheeks, nasolabial folds, forehead and crow's feet.
Hyaluronic acid 15 mg/mL, Phosphate buffer q.b. to 1 mL, Lidocaine 0.3% by mass.
- Avoid taking the injection if you have had dental surgery in the previous 15 days.
- Avoid taking aspirin, anti-inflammatory drugs, anticoagulants and vitamin E during the week before the injection. Seek advice from your doctor before discontinuing any treatment.
- Avoid drinking alcohol or exposure to bright sunlight on the day of the injection and the day before.
- Carefully remove make-up before injection.
After injection, the following recommendations should be taken into account:
- In the 12 hours following the injection: do not apply make-up, avoid any intense exertion.
- During the week following the treatment: avoid alcohol consumption, prolonged exposure to the sun or UV rays, temperatures below 0 °C, and the practice of sauna or hammam.
- Within 15 days after treatment: do not perform dental or other aesthetic procedures.
TEOSYAL® RHA 1 should not be used if:
- One has skin disorders, inflammation or infection at or near the treatment site. Injection procedures may lead to reactivation of latent or subclinical herpes virus infection.
- You are allergic to hyaluronic acid, with a history of severe allergy or anaphylactic shock.
- One is allergic to local anaesthetic agents based on lidocaine and/or amide.
- You have recently undergone peeling, laser or ultrasound treatment.
- You suffer from autoimmune diseases.
- You have heart disease and/or are being treated for heart disease (beta-blockers).
- You have hepatocellular insufficiency and/or are being treated for a liver disease.
- One has epilepsy or porphyria.
- You are pregnant, or breastfeeding, or under the age of 18.
Thanks to its malleability and specific viscoelastic properties, it is evenly distributed in the injected tissue, ensuring an optimal level of dermal hydration and leading to a lasting improvement in skin elasticity.
It is designed to redensify the skin and nourish the dermis in depth, improving radiance and elasticity without creating volume.
Cheeks, forehead, nasolabial folds and crow's feet, helping to restore harmony and a fresh appearance to the face.
The ingredients in the gel diffuse between the cells, stimulating dermal activity, moisturising and redensifying the skin naturally and gradually.
The effects are estimated at least 12 months, thanks to the malleability of the gel and its ability to retain moisture and elasticity over time.
The treatment is contraindicated in cases of allergy to hyaluronic acid or lidocaine, local infections, autoimmune diseases, pregnancy, lactation or children under the age of 18.